## Early clinical products

The industry's most trusted PK/PD platform for non-compartmental analysis (NCA), population PK (popPK), IVIVC, and more.

[Learn more](https://www.certara.com/software/phoenix-pkpd/)

Simcyp PBPK provides physiologically based pharmacokinetic modeling to predict drug behavior in diverse populations.

[Learn more](https://www.certara.com/software/simcyp-pbpk/)

Simcyp Biopharmaceutics software is an advanced PBPK platform for biopharmaceutics, formulation, and CMC experts.

[Learn more](https://www.certara.com/software/simcyp-biopharmaceutics/)

Increase the speed and quality of your clinical trial submission data with the Pinnacle 21® Clinical Data Management & Automation Suite.

[Learn more](https://www.certara.com/pinnacle-21-enterprise-software/)

Accelerate the creation of regulatory documents with AI-generated content, freeing up writers for key analysis, messaging, and refinement.

[Learn more](https://www.certara.com/coauthor/)

Use Certara's AI platform for Life Sciences to solve data silo problems while improving analytics capabilities that boost productivity.

[Learn more](https://www.certara.com/certara-ai/)

## Early clinical services

Our Early Phase Clinical Development solutions provide expert support at every stage, from Candidate Selection through Phase 1.

[Learn more](https://www.certara.com/services/early-development/)

Streamline first-in-human studies with physiologically based modeling to optimize dosing and reduce trial risks.

[Learn more](https://www.certara.com/first-in-human-fih-dose-prediction/)

Analysis and strategies with the main objective of ensuring a successful drug development program.

[Learn more](https://www.certara.com/services/clinical-pharmacology/)

Strategic guidance and end-to-end support to navigate global regulatory pathways, ensuring efficient and compliant drug development from preclinical stages through market approval.

[Learn more](https://www.certara.com/services/early-development/regulatory-affairs-consulting/)

By leveraging quantitative models, regulatory expertise, and real-world data, we empower our partners to fast-track innovative therapies while meeting stringent regulatory standards.

[Learn more](https://www.certara.com/services/therapeutic-areas/rare-disease-drug-development/)